TR200501541T2 - Leu-hirudinin e.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları - Google Patents
Leu-hirudinin e.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekanslarıInfo
- Publication number
- TR200501541T2 TR200501541T2 TR2005/01541T TR200501541T TR200501541T2 TR 200501541 T2 TR200501541 T2 TR 200501541T2 TR 2005/01541 T TR2005/01541 T TR 2005/01541T TR 200501541 T TR200501541 T TR 200501541T TR 200501541 T2 TR200501541 T2 TR 200501541T2
- Authority
- TR
- Turkey
- Prior art keywords
- hirudin
- leu
- coli
- signal sequences
- dissociation
- Prior art date
Links
- 108010076504 Protein Sorting Signals Proteins 0.000 title abstract 3
- 229940006607 hirudin Drugs 0.000 title abstract 3
- 241000588724 Escherichia coli Species 0.000 title abstract 2
- 238000010494 dissociation reaction Methods 0.000 title 1
- 230000005593 dissociations Effects 0.000 title 1
- 239000001963 growth medium Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000007625 Hirudins Human genes 0.000 abstract 1
- 108010007267 Hirudins Proteins 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Karsisinda bulunulan bulus, bir sinyal sekansi ve Leu-Hirudin'in sekansini içeren bir hirudin öncülü, bunun üretimi ve kullanimi ve aynca E.coli'de her hangi proteinlerin ifrazatli ifade edilmesi için sinyal sekanslannin tespitinde uygulanan bir yöntem ve E.coli'de her hangi proteinlerin ifrazatli ifadesi için uygulanan yöntemler.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19944870A DE19944870A1 (de) | 1999-09-18 | 1999-09-18 | Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200501541T2 true TR200501541T2 (tr) | 2005-06-21 |
Family
ID=7922547
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2002/00667T TR200200667T2 (tr) | 1999-09-18 | 2000-09-01 | Leu-hirudinin E.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları. |
| TR2005/01541T TR200501541T2 (tr) | 1999-09-18 | 2000-09-01 | Leu-hirudinin e.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2002/00667T TR200200667T2 (tr) | 1999-09-18 | 2000-09-01 | Leu-hirudinin E.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7455987B1 (tr) |
| EP (1) | EP1216259B1 (tr) |
| JP (1) | JP4669181B2 (tr) |
| KR (1) | KR100737189B1 (tr) |
| CN (2) | CN1192037C (tr) |
| AR (1) | AR025660A1 (tr) |
| AT (1) | ATE357458T1 (tr) |
| AU (1) | AU775923B2 (tr) |
| BR (1) | BR0014519A (tr) |
| CA (1) | CA2385287C (tr) |
| CZ (1) | CZ2002899A3 (tr) |
| DE (2) | DE19944870A1 (tr) |
| DK (1) | DK1216259T3 (tr) |
| EE (1) | EE05187B1 (tr) |
| HR (1) | HRP20020226B1 (tr) |
| HU (1) | HUP0202596A3 (tr) |
| IL (2) | IL148624A0 (tr) |
| ME (1) | MEP27908A (tr) |
| MX (1) | MXPA02002469A (tr) |
| NO (1) | NO329723B1 (tr) |
| NZ (1) | NZ517825A (tr) |
| PL (1) | PL205117B1 (tr) |
| RS (1) | RS50435B (tr) |
| RU (1) | RU2261867C2 (tr) |
| SK (1) | SK287865B6 (tr) |
| TR (2) | TR200200667T2 (tr) |
| WO (1) | WO2001021662A1 (tr) |
| ZA (1) | ZA200202106B (tr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7202059B2 (en) | 2001-02-20 | 2007-04-10 | Sanofi-Aventis Deutschland Gmbh | Fusion proteins capable of being secreted into a fermentation medium |
| US7638618B2 (en) | 2001-02-20 | 2009-12-29 | Sanofi-Aventis Deutschland Gmbh | Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest |
| US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
| CA2546157C (en) * | 2003-11-21 | 2014-07-22 | Dow Global Technolgies Inc. | Improved expression systems with sec-system secretion |
| BRPI0513826A2 (pt) | 2004-07-26 | 2010-06-22 | Dow Global Technologies Inc | processo para expressão de proteìna melhorada através de engenharia de cepa |
| DE102005046113A1 (de) * | 2005-09-27 | 2007-03-29 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Amidierung von Polypetiden mit C-terminalen basischen Aminosäuren unter Verwendung spezifischer Endoproteasen |
| DE102006044841A1 (de) * | 2006-09-22 | 2008-04-03 | Wacker Chemie Ag | Signalpeptid zur Produktion von rekombinanten Proteinen |
| EP2468869B1 (en) | 2007-01-31 | 2015-03-18 | Pfenex Inc. | Bacterial leader sequences for increased expression |
| US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| US9394571B2 (en) | 2007-04-27 | 2016-07-19 | Pfenex Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| PL2968470T3 (pl) | 2013-03-12 | 2021-05-31 | The General Hospital Corporation | Zmodyfikowane białka stanowiące substancję hamującą rozwój przewodów müllera (mis) i ich zastosowania do leczenia chorób |
| ES2912283T3 (es) | 2013-12-11 | 2022-05-25 | Massachusetts Gen Hospital | Uso de proteínas de tipo sustancia inhibidora mülleriana (SIM) para la anticoncepción y conservación de la reserva ovárica |
| CN108220369B (zh) * | 2017-12-04 | 2021-03-12 | 广东双骏生物科技有限公司 | 一种生产重组水蛭素的方法 |
| CN108359689B (zh) * | 2018-01-19 | 2021-03-23 | 华中农业大学 | 利用抗病基因识别无毒效应蛋白以鉴定具有分泌功能信号肽的方法 |
| CN115572329B (zh) * | 2021-06-21 | 2024-02-06 | 王大勇 | 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3429430A1 (de) * | 1984-08-10 | 1986-02-20 | Hoechst Ag, 6230 Frankfurt | Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens |
| IL88925A (en) * | 1985-04-11 | 1995-11-27 | Hoechst Ag | Hirudin derivative and pharmaceutical composition containing same |
| US5084384A (en) * | 1987-04-23 | 1992-01-28 | Monsanto Company | Secretion of insulin-like growth factor-I |
| AU604925B2 (en) * | 1988-02-23 | 1991-01-03 | Schering Aktiengesellschaft | A hirudin derivative |
| DE4009268A1 (de) * | 1990-03-22 | 1991-09-26 | Consortium Elektrochem Ind | Sekretion von hirudinderivaten |
| ES2093717T3 (es) * | 1990-11-08 | 1997-01-01 | Japan Energy Corp | Mutante de hirudina, su produccion, anticoagulante, vector secretor, microorganismo transformado por el indicado vector y produccion de un producto a partir de dicho microorganismo. |
| JPH07119237B2 (ja) * | 1990-11-08 | 1995-12-20 | 株式会社ジャパンエナジー | ヒルジン変異体，その製造法及び抗凝血剤 |
| PT100580A (pt) * | 1991-06-12 | 1993-09-30 | Regeneron Pharma | Producao e recuperacao de neurotrofinas recombinantes |
| US5389529A (en) * | 1991-06-12 | 1995-02-14 | Regeneron Pharmaceuticals, Inc. | Modified lamβ signal sequence and processes for producing recombinant neurotrophins |
| DE4140381A1 (de) | 1991-12-07 | 1993-06-09 | Hoechst Ag, 6230 Frankfurt, De | Neue synthetische isohirudine mit verbesserter stabilitaet |
-
1999
- 1999-09-18 DE DE19944870A patent/DE19944870A1/de not_active Withdrawn
-
2000
- 2000-09-01 WO PCT/EP2000/008537 patent/WO2001021662A1/de not_active Ceased
- 2000-09-01 CZ CZ2002899A patent/CZ2002899A3/cs unknown
- 2000-09-01 RU RU2002110278/13A patent/RU2261867C2/ru not_active IP Right Cessation
- 2000-09-01 AU AU68421/00A patent/AU775923B2/en not_active Ceased
- 2000-09-01 NZ NZ517825A patent/NZ517825A/en not_active IP Right Cessation
- 2000-09-01 MX MXPA02002469A patent/MXPA02002469A/es active IP Right Grant
- 2000-09-01 JP JP2001525235A patent/JP4669181B2/ja not_active Expired - Fee Related
- 2000-09-01 TR TR2002/00667T patent/TR200200667T2/tr unknown
- 2000-09-01 SK SK362-2002A patent/SK287865B6/sk not_active IP Right Cessation
- 2000-09-01 EE EEP200200139A patent/EE05187B1/xx not_active IP Right Cessation
- 2000-09-01 TR TR2005/01541T patent/TR200501541T2/tr unknown
- 2000-09-01 KR KR1020027003577A patent/KR100737189B1/ko not_active Expired - Fee Related
- 2000-09-01 DE DE50014189T patent/DE50014189D1/de not_active Expired - Lifetime
- 2000-09-01 ME MEP-279/08A patent/MEP27908A/xx unknown
- 2000-09-01 AT AT00956507T patent/ATE357458T1/de not_active IP Right Cessation
- 2000-09-01 CA CA2385287A patent/CA2385287C/en not_active Expired - Fee Related
- 2000-09-01 HR HR20020226A patent/HRP20020226B1/xx not_active IP Right Cessation
- 2000-09-01 BR BR0014519-0A patent/BR0014519A/pt not_active Application Discontinuation
- 2000-09-01 HU HU0202596A patent/HUP0202596A3/hu unknown
- 2000-09-01 RS YUP-146/02A patent/RS50435B/sr unknown
- 2000-09-01 EP EP00956507A patent/EP1216259B1/de not_active Expired - Lifetime
- 2000-09-01 DK DK00956507T patent/DK1216259T3/da active
- 2000-09-01 PL PL354444A patent/PL205117B1/pl not_active IP Right Cessation
- 2000-09-01 CN CNB00812955XA patent/CN1192037C/zh not_active Expired - Fee Related
- 2000-09-01 IL IL14862400A patent/IL148624A0/xx unknown
- 2000-09-01 CN CNB2004100346716A patent/CN1269838C/zh not_active Expired - Fee Related
- 2000-09-14 AR ARP000104820A patent/AR025660A1/es active IP Right Grant
- 2000-09-18 US US09/664,326 patent/US7455987B1/en not_active Expired - Lifetime
-
2002
- 2002-03-11 IL IL148624A patent/IL148624A/en not_active IP Right Cessation
- 2002-03-13 NO NO20021254A patent/NO329723B1/no not_active IP Right Cessation
- 2002-03-14 ZA ZA200202106A patent/ZA200202106B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200501541T2 (tr) | Leu-hirudinin e.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları | |
| DK0981630T3 (da) | Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme | |
| BG103251A (bg) | Оксадиазоли, методи за получаването им и приложението им като лекарствени средства | |
| DE69403642D1 (de) | 7-deazapurin modifizierte oligonukleotide | |
| BR0109062A (pt) | Inibidores de frutose-1,6-bisfosfatase de arila | |
| CY1107628T1 (el) | Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων | |
| DE60033138D1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
| DE69942459D1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
| WO2001064835A8 (en) | Novel nucleic acids and polypeptides | |
| WO2001064834A8 (en) | Novel nucleic acids and polypeptides | |
| DE60139544D1 (de) | Veränderte, fluoreszierende proteine | |
| AUPP472398A0 (en) | Protease susceptibility II | |
| ATE285474T1 (de) | Haemophilus adhäsionsproteinen | |
| ATE316577T1 (de) | Das goodpasture-antigen bindende protein | |
| NO20005608D0 (no) | Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav | |
| DE50110723D1 (de) | Isolierte luziferasen sowie deren verwendung | |
| ATE309370T1 (de) | Retinoid-metabolisierendes protein | |
| DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
| DE10342670A1 (de) | Isoliertes Photoprotein mtClytin, sowie dessen Verwendung | |
| TR199902434T2 (tr) | Bakteriyel plazmidler. | |
| DE69838615D1 (de) | ppGpp-SYNTHETASE UND EXPRESSIONSSYSTEME ZUR VERBESSERTEN HERSTELLUNG VON PROTEINEN | |
| NO20020329L (no) | Antitumor-antistoffer, proteiner og anvendelse derav | |
| EP1191096A4 (en) | NEW PROTEIN AND ITS DNA | |
| WO2005057486A3 (en) | Protein engineering with analogous contact environments | |
| DE59611293D1 (de) | Protein mit dnase-aktivität |